Search

We studied uterine cancer patients who presented to the two public hospitals in Queens, New York from 2006 to 2015 with the purpose of examining the relationship between nativity (birthplace) and survival. A retrospective review of tumor registries was used to identify patients diagnosed with uterine cancer between January 1, 2006 and December 31, 2015. Using electronic medical records, data from 260 patients were available for this analysis. The majority of patients were born outside the United States (US) (76.2% versus 23.8%). The majority of US-born patients were BlackBlack (67.7%). Ninety-five patients (36.5%) were born in the Caribbean Islands, 59 in Latin America (22.7%) and 44 in Asia/South Asia (16.9%). Most patients presented with stage I/II disease (69.7%) and stage did not vary significantly by nativity. Endometrioid/mucinous histology (67.8%) was the most common followed by serous/clear cell (17.7%) and uterine sarcomas (11.4%) with no significant difference in histology among nativity groups. Kaplan-Meier estimated survival curves stratified by birthplace demonstrated significant differences in survival distributions among the groups using the log-rank test (P<0.001). The most favorable survival curves were observed among patients born in Latin America and Asia/South Asia whereas the least favorable was demonstrated in US-born patients (Figure 1). Time to death was analyzed using the Cox proportional hazards model. Adjusting for age of diagnosis, insurance status, stage and treatment modality, Latin American birthplace was significantly associated with survival time (P=0.0274); Asian/South Asian birthplace demonstrated a strong trend towards a significant difference (P=0.0530). [Display omitted] A Latin American health paradox was defined for foreign-born Latino patients presenting to the two Public Hospitals of Queens, New York as patients born in Latin America were less likely to die at any given time compared to those born in the United States. [ABSTRACT FROM AUTHOR]